A Study of ASP1941 in Combination With Insulin in Patients With Type 1 Diabetes Mellitus

NCT02897219 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

175

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 1 Diabetes Mellitus

Interventions

DRUG: ipragliflozin
DRUG: Placebo
OTHER: Insulin Therapy

Sponsor

Astellas Pharma Inc